Adam Steensberg

Adam ALR0674
Role

President and Chief Executive Officer

Location

Søborg, Denmark

Experience

Adam was appointed to the position of CEO at Zealand Pharma in March 2022 and has 20+ years of experience in both the private and public sectors. Adam has led a significant transformation of Zealand and period of growth for the company. Prior to being appointed CEO, Adam served for several years as Zealand’s Chief Medical Officer and Head of Research & Development and was responsible for the company’s R&D strategy and portfolio of drug candidates. Prior to joining Zealand, Adam led clinical research teams as medical director at Novo Nordisk and worked as a clinician at Rigshospitalet, University of Copenhagen. 

His was also as a medical and scientific advisor in the areas of endocrinology, cardiology, gastroenterology and rheumatology, and has significant experience of leading regulatory strategies. 

Adam is a Board Member at DANISH BIO - DANSK BIOTEK.

Education

Adam is a certified medical doctor and holds a Doctor of Medical Sciences degree (D.M.Sc./dr.med.) from the University of Copenhagen, Denmark, and an MBA from IMD, Switzerland. Adam has published more than 45 peer-reviewed scientific papers in renowned international journals.

Share profile

  • LINKEDIN